United States · FDA National Drug Code directory

Tadalafil

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76420-553_f7f0bf23-1272-256a-e053-6294a90a40ee
Product NDC
76420-553
Form
TABLET
Composition / generic term
Tadalafil
Labeler
Asclemed USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20190326
Source listing expiry
20261231

Source-listed ingredients

  • TADALAFIL — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 TABLET in 1 BOTTLE (76420-553-05) · 76420-553-05
  • 120 TABLET in 1 BOTTLE (76420-553-12) · 76420-553-12
  • 30 TABLET in 1 BOTTLE (76420-553-30) · 76420-553-30
  • 60 TABLET in 1 BOTTLE (76420-553-60) · 76420-553-60
  • 90 TABLET in 1 BOTTLE (76420-553-90) · 76420-553-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →